InsiderTrades.com logo

OVID Insider Trading

Insider Ownership Percentage: 13.30%
Insider Buying (Last 12 Months): $4,971.30
Insider Selling (Last 12 Months): $0.00

Ovid Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Ovid Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ovid Therapeutics Share Price & Price History

Current Price: $0.46
Price Change: ▼ Price Decrease of -0.0057 (-1.22%)
As of 03/18/2025 05:00 PM ET

This chart shows the closing price history over time for OVID up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ovid Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2025Margaret A AlexanderCOOBuy6,810$0.73$4,971.3034,935View SEC Filing Icon  
3/18/2024Jeremy M LevinCEOBuy18,248$2.76$50,364.483,616,715View SEC Filing Icon  
9/12/2022Jason TardioCOOSell17,344$2.15$37,289.60View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ovid Therapeutics (NASDAQ:OVID)

72.24% of Ovid Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OVID by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ovid Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Velan Capital Investment Management LP70,000$65K0.1%N/A0.099%Search for SEC Filing on Google Icon
2/17/2025Madison Avenue Partners LP3,722,627$3.48M0.4%-9.6%5.242%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 943,416$0.88M0.1%+50.2%1.329%Search for SEC Filing on Google Icon
2/17/2025Jacobs Levy Equity Management Inc.291,701$0.27M0.0%N/A0.411%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC229,115$0.21M0.0%-26.0%0.323%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE56,733$53K0.0%+49.7%0.080%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets104,712$98K0.0%-52.5%0.147%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.1,000,000$0.93M0.0%N/A1.408%Search for SEC Filing on Google Icon
2/13/2025Kennedy Capital Management LLC1,545,387$1.44M0.0%+1.1%2.176%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC107,700$0.10M0.0%+142.0%0.152%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC130,532$0.12M0.0%+245.8%0.184%Search for SEC Filing on Google Icon
2/12/2025TLS Advisors LLC680,967$0.64M1.5%-11.7%0.959%Search for SEC Filing on Google Icon
2/12/2025Takeda Pharmaceutical Co. Ltd.7,531,996$7.01M26.4%N/A10.607%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.1,418,306$1.32M0.0%-3.1%1.997%Search for SEC Filing on Google Icon
2/10/2025Monimus Capital Management LP138,266$0.13M0.1%N/A0.195%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers84,078$79K0.0%+22.3%0.118%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC37,636$35K0.0%+83.9%0.053%Search for SEC Filing on Google Icon
1/14/2025Assenagon Asset Management S.A.70,114$65K0.0%-18.7%0.099%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC84,175$98K0.0%+311.2%0.119%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,317,330$1.56M0.0%+1.1%1.855%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC84,175$98K0.0%+311.2%0.119%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd38,230$45K0.0%+46.2%0.054%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC38,399$45K0.0%-61.1%0.054%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC74,875$88K0.0%N/A0.105%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets220,401$0.26M0.0%+4,128.7%0.311%Search for SEC Filing on Google Icon
11/13/2024FMR LLC50,225$59K0.0%+1,907.4%0.071%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP260,509$0.31M0.0%+118.0%0.367%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.86,289$0.10M0.0%N/A0.122%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC1,400,191$1.08M0.0%N/A1.974%Search for SEC Filing on Google Icon
8/13/2024DCF Advisers LLC41,750$32K0.0%+111.6%0.059%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC141,200$0.11M0.0%-9.9%0.199%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP274,982$0.21M0.0%-19.6%0.388%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers69,733$54K0.0%-15.6%0.098%Search for SEC Filing on Google Icon
8/1/2024FFT Wealth Management LLC489,552$0.38M0.0%+18.2%0.690%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp218,163$0.17M0.0%-5.0%0.308%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL3,853,818$11.75M0.3%-43.7%5.442%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD17,396$54K0.0%+22.1%0.025%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,976,308$9.08M0.0%-0.5%4.203%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC35,938$0.11M0.0%-9.7%0.051%Search for SEC Filing on Google Icon
5/7/2024Empowered Funds LLC128,070$0.39M0.0%+8.1%0.181%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets32,162$98K0.0%+74.7%0.045%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.13,579$41K0.0%+66.0%0.019%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.114,265$0.35M0.0%+45.6%0.162%Search for SEC Filing on Google Icon
2/14/2024Rubric Capital Management LP5,315,969$17.12M0.4%-2.4%7.521%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP85,429$0.28M0.0%N/A0.121%Search for SEC Filing on Google Icon
2/13/2024DCF Advisers LLC18,730$60K0.0%-38.4%0.026%Search for SEC Filing on Google Icon
2/6/2024FFT Wealth Management LLC395,774$1.27M0.1%N/A0.560%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.8,178$26K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.78,479$0.25M0.0%N/A0.111%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC39,792$0.13M0.0%+52.7%0.056%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.81,173$0.31M0.0%+17.2%0.115%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC1,701,228$6.53M0.0%-4.5%2.407%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund19,110$73K0.0%-28.7%0.027%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC15,811$61K0.0%N/A0.022%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC26,064$100K0.0%N/A0.037%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC11,955$40K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP5,445,910$17.86M0.8%-22.2%7.714%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd112,591$0.37M0.2%-5.2%0.159%Search for SEC Filing on Google Icon
8/9/2023DCF Advisers LLC64,764$0.21M0.1%-5.1%0.092%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.28,701$94K0.0%N/A0.041%Search for SEC Filing on Google Icon
7/27/2023EA Series Trust98,952$0.33M0.0%N/A0.140%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates25,000$82K0.0%N/A0.035%Search for SEC Filing on Google Icon
5/15/2023Madison Avenue Partners LP3,104,603$8.01M1.7%+14.1%4.402%Search for SEC Filing on Google Icon
5/15/2023Rubric Capital Management LP7,001,124$18.06M0.5%+2.5%9.928%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd118,791$0.31M0.2%+10.5%0.168%Search for SEC Filing on Google Icon
5/11/2023Acadian Asset Management LLC1,780,873$4.59M0.0%-1.9%2.525%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.30,858$80K0.0%-22.7%0.044%Search for SEC Filing on Google Icon
5/9/2023Y Intercept Hong Kong Ltd35,116$91K0.0%N/A0.050%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC17,892$46K0.0%N/A0.025%Search for SEC Filing on Google Icon
2/10/2023Blair William & Co. IL24,328$45K0.0%-22.1%0.035%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP4,516,300$8.31M0.4%+56.7%6.409%Search for SEC Filing on Google Icon
11/10/2022Stonepine Capital Management LLC1,540,671$2.84M1.3%-55.8%2.188%Search for SEC Filing on Google Icon
10/18/2022Newman Dignan & Sheerar Inc.15,522$29K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/16/2022Driehaus Capital Management LLC1,343,325$2.89M0.0%+273.2%1.908%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC26,831$59K0.0%-96.4%0.038%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.36,748$79K0.0%-57.7%0.052%Search for SEC Filing on Google Icon
7/29/2022Walker Asset Management LLC43,400$0.11M0.0%N/A0.062%Search for SEC Filing on Google Icon
7/29/2022Russell Investments Group Ltd.267,868$0.57M0.0%-2.9%0.380%Search for SEC Filing on Google Icon
7/27/2022Assenagon Asset Management S.A.26,362$57K0.0%N/A0.037%Search for SEC Filing on Google Icon
7/25/2022Walker Asset Management LLC43,400$0.11M0.0%N/A0.062%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC2,139,290$6.72M0.0%+4.9%3.038%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.86,888$0.27M0.0%-27.3%0.123%Search for SEC Filing on Google Icon
5/9/2022Bank of Nova Scotia47,350$0.15M0.0%+12.1%0.067%Search for SEC Filing on Google Icon
5/5/2022Royce & Associates LP11,811$37K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.275,973$0.87M0.0%-10.0%0.392%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC4,006,185$12.86M5.9%+23.2%5.883%Search for SEC Filing on Google Icon
2/14/2022Blair William & Co. IL90,852$0.29M0.0%-6.3%0.133%Search for SEC Filing on Google Icon
2/10/2022Bailard Inc.47,948$0.15M0.0%N/A0.070%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd13,989$45K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC2,040,084$6.54M0.0%+7.2%2.996%Search for SEC Filing on Google Icon
2/10/2022WINTON GROUP Ltd11,829$38K0.0%-78.1%0.017%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.119,573$0.38M0.0%-40.1%0.176%Search for SEC Filing on Google Icon
2/8/2022First Trust Advisors LP84,852$0.27M0.0%+14.3%0.125%Search for SEC Filing on Google Icon
2/7/2022American Century Companies Inc.46,881$0.15M0.0%+23.9%0.069%Search for SEC Filing on Google Icon
2/4/2022Boston Partners84,261$0.27M0.0%N/A0.124%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd13,989$45K0.0%N/A0.021%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.306,556$0.98M0.0%N/A0.450%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC10,100$34K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP108,000$0.36M0.0%-67.5%0.159%Search for SEC Filing on Google Icon
11/16/2021CHI Advisors LLC233,510$0.79M0.2%+6.9%0.344%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ovid Therapeutics logo
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Read More on Ovid Therapeutics

Today's Range

Now: $0.46
Low: $0.45
High: $0.48

50 Day Range

MA: $0.63
Low: $0.43
High: $0.91

52 Week Range

Now: $0.46
Low: $0.42
High: $3.45

Volume

273,955 shs

Average Volume

420,155 shs

Market Capitalization

$32.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.29

Who are the company insiders with the largest holdings of Ovid Therapeutics?

Ovid Therapeutics' top insider shareholders include:
  1. Jeremy M Levin (CEO)
  2. Margaret A Alexander (COO)
Learn More about top insider investors at Ovid Therapeutics.

Who are the major institutional investors of Ovid Therapeutics?

Ovid Therapeutics' top institutional investors include:
  1. Takeda Pharmaceutical Co. Ltd. — 10.61%
  2. Madison Avenue Partners LP — 5.24%
  3. Kennedy Capital Management LLC — 2.18%
  4. JPMorgan Chase & Co. — 2.00%
  5. Adage Capital Partners GP L.L.C. — 1.41%
  6. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC — 1.33%
Learn More about top institutional investors of Ovid Therapeutics stock.

Which institutional investors are selling Ovid Therapeutics stock?

During the last quarter, OVID stock was sold by these institutional investors:
  1. Madison Avenue Partners LP
  2. BNP Paribas Financial Markets
  3. TLS Advisors LLC
  4. Bridgeway Capital Management LLC
  5. JPMorgan Chase & Co.
  6. Assenagon Asset Management S.A.
  7. Citadel Advisors LLC

Which institutional investors are buying Ovid Therapeutics stock?

Within the last quarter, OVID stock was purchased by institutional investors including:
  1. Takeda Pharmaceutical Co. Ltd.
  2. Adage Capital Partners GP L.L.C.
  3. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC
  4. Jacobs Levy Equity Management Inc.
  5. Monimus Capital Management LP
  6. ADAR1 Capital Management LLC
  7. Velan Capital Investment Management LP
  8. Renaissance Technologies LLC
In the last year, these company insiders have bought Ovid Therapeutics stock:
  1. Jeremy M Levin (CEO)
  2. Margaret A Alexander (COO)
Learn More investors buying Ovid Therapeutics stock.